Very important pharmacogene summary
Laura M. Hodges, Svetlana M. Markova, Leslie W. Chinn et al. · Pharmacogenetics and Genomics · 2010
Hodges, Laura M.; Markova, Svetlana M.; Chinn, Leslie W.; Gow, Jason M.; Kroetz, Deanna L.; Klein, Teri E.; Altman, Russ B. Author Information
Cited by 436 works. doi:10.1097/fpc.0b013e3283385a1c
Authors
References
- A haplotype map of the human genome
- A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants
- Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic, and cytogenetic studies.
- Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
- Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines
- Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo
- BIOCHEMICAL, CELLULAR, AND PHARMACOLOGICAL ASPECTS OF THE MULTIDRUG TRANSPORTER
- The multidrug transporter, a double-edged sword.
- MDR1 P-Glycoprotein Is a Lipid Translocase of Broad Specificity, While MDR3 P-Glycoprotein Specifically Translocates Phosphatidylcholine
- Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P‐glycoprotein: Implications for drug delivery and activity in cancer chemotherapy